August 29, 2022
After a nearly five week trial, the six jurors in the Paul Trevino v. C.R. Bard hernia mesh case came back with $4.8 Million for Paul Trevino and his family.
The case will accrue interest and is expected to exceed $7 million when it is finally awarded.
Closing arguments in the case were heard last Tuesday and jurors have been deliberating since then. When they could not reach a conclusion on Friday, they were told to return Monday to see if they could agree.
Trevino, 61, a municipal employee in Hawaii, was implanted with a Bard Ventralex hernia mesh in 2008 and years later it had to be surgically removed along with a section of his bowel. Trevino says he is disabled after nine surgeries to deal with fistula formation around the mesh and chronic infections.
Jonathan Orent (Motley Rice) told jurors the Ventralex patch can buckle and contract, which causes internal injuries. He also argued that Bard sought a non-medical grade polypropylene to make the Ventralex in order to cut costs.
Jurors were shown emails among company executives to keep secret the end product from the polypropylene supplier after the supplier specifically warned the polypropylene was not to be used in implantable devices.
Jeff Scott of Greenberg Traurig told the six jurors and three alternates that Ventralex is still on the market and has helped the vast majority of patients using it.
To read the full article from Mesh News Desk click here.